From the Departments of Pathology (C.S.-R., M.D., O.S.) and Biochemistry (C.S.-R., M.d.W., E.L.), Academic Medical Center, Amsterdam, the Netherlands; Institute for Cardiovascular Prevention, Ludwig Maximilian University of Munich, Munich, Germany (C.W., E.L., O.S.); and Deutsches Zentrum für Herz-Kreislauf-Forschung e.V. (DZHK) (German Centre for Cardiovascular Research), partner site of Munich Heart Alliance, Munich, Germany (C.W., O.S.).
Circ Res. 2014 Jan 3;114(1):214-26. doi: 10.1161/CIRCRESAHA.114.302355.
Understanding the pathophysiology of atherogenesis and the progression of atherosclerosis have been major goals of cardiovascular research during the previous decades. However, the complex molecular and cellular mechanisms underlying plaque destabilization remain largely obscure. Here, we review how lesional cells undergo cell death and how failed clearance exacerbates necrotic core formation. Advanced atherosclerotic lesions are further weakened by the pronounced local activity of matrix-degrading proteases as well as immature neovessels sprouting into the lesion. To stimulate translation of the current knowledge of molecular mechanisms of plaque destabilization into clinical studies, we further summarize available animal models of plaque destabilization. Based on the molecular mechanisms leading to plaque instability, we outline the current status of clinical and preclinical trials to induce plaque stability with a focus on induction of dead cell clearance, inhibition of protease activity, and dampening of inflammatory cell recruitment.
了解动脉粥样硬化形成的病理生理学和动脉粥样硬化的进展一直是过去几十年心血管研究的主要目标。然而,斑块不稳定的复杂分子和细胞机制在很大程度上仍不清楚。在这里,我们回顾了病变细胞如何发生细胞死亡,以及清除失败如何加剧坏死核心的形成。高级动脉粥样硬化病变进一步因局部基质降解蛋白酶的显著活性以及不成熟的新血管向病变中生长而减弱。为了将目前关于斑块不稳定的分子机制的知识转化为临床研究,我们进一步总结了现有的斑块不稳定动物模型。基于导致斑块不稳定的分子机制,我们概述了目前用于诱导斑块稳定性的临床前和临床试验的现状,重点是诱导死亡细胞清除、抑制蛋白酶活性和抑制炎症细胞募集。